
Ro Khanna @RoKhanna
The average price of Humalog U100 — a widely used insulin — rose 52 percent between 2014 and 2017. Instead of giving Eli Lilly tax breaks so they pay $0 in federal income tax, we should end their patent abuse and authorize generic competition for insulin. — PolitiTweet.org